With the finding that GILZ controls the proliferation of dormant melanoma cells, especially those with stem cell characteristics, an intriguing new field of investigation has opened up that may link GCs, GILZ, the immune system, and neoplastic development. This evidence concerns the gene TSC22D3 and melanoma.